Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
AB-001 by Agastiya Biotech for Gallbladder Cancer: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase II for Gallbladder Cancer. According to GlobalData, Phase...
AB-001 by Agastiya Biotech for Liver Cancer: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase II for Liver Cancer. According to GlobalData, Phase...
AB-001 by Agastiya Biotech for Colon Cancer: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase II for Colon Cancer. According to GlobalData, Phase...
AB-001 by Agastiya Biotech for Breast Cancer: Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase II for Breast Cancer. According to GlobalData, Phase...
AB-001 by Agastiya Biotech for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
AB-001 is under clinical development by Agastiya Biotech and currently in Phase I for Triple-Negative Breast Cancer (TNBC). According to...